English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Regulatory

+ Regulatory
H. K. Adler | Jul 7, 2026

Save Our States: '340B drug discount program is being abused while nonprofit hospitals spend big on luxury renovations'

+ Regulatory
Patient Daily | Jul 7, 2026

Neurology nurse practitioner Celia McIntosh discusses career path and specialty challenges

+ Regulatory
A. B. Adkins | Jul 6, 2026

COA executive director: '340B dollars are meant for patients in need, not corporate profits'

+ Regulatory
A. K. Velazquez | Jul 1, 2026

Partnership for Innovation and Empowerment: Nonprofit hospitals 'rake in profits and charge patients more'

+ Regulatory
Patient Daily | Jun 30, 2026

AANP welcomes interim guidance on federal student loan access for graduate nursing programs

+ Regulatory
Patient Daily | Jun 29, 2026

Public Policy Solutions: Hospitals are 'panicking over basic accountability'

+ Regulatory
A. P. Berry | Jun 25, 2026

Pharmacy benefits consultant: 'Most plan sponsors have never been shown' the generic spread their PBM charges

+ Regulatory
Patient Daily | Jun 25, 2026

Real America's Voice: 340B program envisioned for neighborhood clinics has grown into 'taxpayer-supported enterprises'

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily